Clinilabs invites you to their event
About this event
Join the Sleep Disorders Institute and Clinilabs to learn more about Obstructive Sleep Apnea.
Attendees will gain an understanding of (a) the early warning signs of Sleep Apnea, (b) the risk factors and consequences of untreated Sleep Apnea, (c) signs you should see your Doctor (d) how it is diagnosed in home sleep testing versus in-lab, (e) clinical trials available to treat Sleep Apnea tomorrow.
Hosted by
Ms. Jeanine Falinski, VP of Strategy and Corporate Development, has more than 20 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing, later on receiving her MBA in Pharmaceutical Management from Drexel University.
Gary Zammit is a neuroscientist and sleep specialist who founded Clinilabs Drug Development Corporation in 2001. He is widely recognized as a key opinion leader in the field of sleep medicine, and has been involved in the development of new drugs to treat sleep disorders such as narcolepsy, insomnia, excessive sleepiness, and circadian rhythm disorders.
We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.
